You are here

Amgen

Amgen vows to fight after IRS demands $3.6B in back taxes—and a bigger bill could be on the way

Fierce Pharma

Wed, 08/4/21 - 11:06 am

Amgen splashes $550M and plans to hire hundreds in manufacturing push into the Tarheel State

Fierce Pharma

Tue, 08/3/21 - 11:58 pm

drug manufacturing

AstraZeneca and Amgen quietly admit tezepelumab defeat as the Dupixent challenger heads to FDA

Endpoints

Thu, 07/29/21 - 11:10 am

Amgen pays $900M for Teneobio and bets bigger on next-gen antibody drugs

BioPharma Dive

Wed, 07/28/21 - 07:22 pm

Otezla maker Amgen challenges patient groups to help fix long-lasting psoriasis treatment gaps

Fierce Pharma

Fri, 07/23/21 - 11:05 am

Frontier Medicines raises $88M for R&D, including potential rival to Amgen cancer drug

MedCity News

Wed, 07/21/21 - 12:06 am

Frontier Medicines

Amgen's Neulasta banner draws OPDP’s second letter of 2021

RAPS.org

Wed, 07/14/21 - 10:54 pm

The top 15 blockbuster patent expirations coming this decade

Fierce Pharma

Mon, 07/12/21 - 11:08 am

Amgen in $365m ‘smart facility’ manufacturing expansion

Biopharma Reporter

Thu, 07/1/21 - 10:30 am

drug manufacturing

Amgen adds 400 jobs in central Ohio as part of an expansion of its packaging operations

Endpoints

Tue, 06/29/21 - 11:00 am

drug manufacturing

Amgen dealt another blow in closely watched PCSK9 patent case against Sanofi, Regeneron

Fierce Pharma

Tue, 06/22/21 - 11:56 am

PCSK9 inhibitors

Amgen follows Sanofi into a new dermatitis mechanism

EP Vantage

Tue, 06/1/21 - 10:58 am

atopic dermatitis

Amgen lands first FDA approval for drug targeting elusive mutation in lung cancer

MedCity News

Sat, 05/29/21 - 04:52 pm

Sandoz's Enbrel biosim case turned away at SCOTUS, giving Amgen's blockbuster 8 more years of free rein

Fierce Pharma

Mon, 05/17/21 - 10:59 pm

ACC 2021: With Amgen out of the picture, Cytokinetics imagines supporting role for omecamtiv in heart failure

Fierce Biotech

Mon, 05/17/21 - 10:48 am

Omecamtiv Mecarbil

Amgen, AstraZeneca's tezepelumab is looking for a slice of blockbuster asthma market dominated by Sanofi's Dupixent

Fierce Biotech

Thu, 05/13/21 - 10:57 am

Amgen asks FDA for approval of key asthma drug

BioPharma Dive

Mon, 05/10/21 - 08:15 pm

Pandemic slowed sales of cancer, arthritis, diabetes drugs

Beckers Hospital Review

Mon, 05/3/21 - 10:48 am

Amgen’s low-dose Kras curveball

EP Vantage

Thu, 04/29/21 - 10:40 am

Why Amgen's Q1 Results Disappointed Investors

Motley Fool

Wed, 04/28/21 - 10:18 am

Pages